Cubist Systematic Strategies, LLC Dare Bioscience, Inc. Transaction History

Cubist Systematic Strategies, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$0.94 - $1.76 $15,828 - $29,636	16,839 New	16,839 $21,000
Q1 2022 May 16, 2022	SELL	$1.42 - $2.09 $109,784 - $161,584	-77,313 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$1.42 - $2.13 $109,784 - $164,676	77,313 New	77,313 $155,000

267K

Ticker DARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,820,896
Market Cap $271M
Description
Daré Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in the identifying, developing, and marketing products for women's health in the United States. It develops therapies in the areas of contraception, fertility, and sexual and vaginal health. The company's product includes XACIATO, a single-dose vaginal gel prescription pr...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.